| 产品编号 | CFN60066 | |
| CAS编号 | 955365-80-7 | |
| 分子式 = 分子量 | C27H32N8O2 = 500.6 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| Adavosertib (MK-1775) | CFN60066 | 955365-80-7 | 1mg | QQ客服:2056216494 |
| Adavosertib (MK-1775) | CFN60066 | 955365-80-7 | 5mg | QQ客服:2056216494 |
| Adavosertib (MK-1775) | CFN60066 | 955365-80-7 | 10mg | QQ客服:2056216494 |
| Adavosertib (MK-1775) | CFN60066 | 955365-80-7 | 20mg | QQ客服:2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Adavosertib (MK-1775, AZD1775) is a potent and selective Wee1 inhibitor with IC50 of 5.2 nM in a cell-free assay; hinders G2 DNA damage checkpoint. |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.9976 mL | 9.988 mL | 19.976 mL | 39.9521 mL | 49.9401 mL |
| 5 mM | 0.3995 mL | 1.9976 mL | 3.9952 mL | 7.9904 mL | 9.988 mL |
| 10 mM | 0.1998 mL | 0.9988 mL | 1.9976 mL | 3.9952 mL | 4.994 mL |
| 50 mM | 0.04 mL | 0.1998 mL | 0.3995 mL | 0.799 mL | 0.9988 mL |
| 100 mM | 0.02 mL | 0.0999 mL | 0.1998 mL | 0.3995 mL | 0.4994 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 反式肉桂酰基beta-D-葡糖苷; trans-Cinnamoyl beta-D-glucoside | CFN95497 | 13080-39-2 | C15H18O8 = 326.3 | 5mg | QQ客服:1413575084 |
| 16,25-Diacetate cyclosiversioside F; 16,25-Diacetate cyclosiversioside F | CFN91772 | 452919-90-3 | C45H72O16 = 869.04 | 5mg | QQ客服:215959384 |
| 20(R)-原人参三醇; 20(R)-Protopanaxatriol | CFN99980 | 1453-93-6 | C30H52O4 = 476.73 | 20mg | QQ客服:1457312923 |
| 木兰苷B; Magnoloside B | CFN91539 | 116872-05-0 | C35H46O20 = 786.7 | 5mg | QQ客服:1413575084 |